GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao NovelBeam Technology Co Ltd (SHSE:688677) » Definitions » Capex-to-Revenue

Qingdao NovelBeam Technology Co (SHSE:688677) Capex-to-Revenue : 0.13 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qingdao NovelBeam Technology Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Qingdao NovelBeam Technology Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-14.70 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥117.64 Mil.

Hence, Qingdao NovelBeam Technology Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.13.


Qingdao NovelBeam Technology Co Capex-to-Revenue Historical Data

The historical data trend for Qingdao NovelBeam Technology Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao NovelBeam Technology Co Capex-to-Revenue Chart

Qingdao NovelBeam Technology Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.16 0.25 0.32 0.21 0.12

Qingdao NovelBeam Technology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.13 0.24 0.13

Competitive Comparison of Qingdao NovelBeam Technology Co's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Qingdao NovelBeam Technology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao NovelBeam Technology Co's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao NovelBeam Technology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Qingdao NovelBeam Technology Co's Capex-to-Revenue falls into.



Qingdao NovelBeam Technology Co Capex-to-Revenue Calculation

Qingdao NovelBeam Technology Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-55.978) / 470.597
=0.12

Qingdao NovelBeam Technology Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-14.704) / 117.642
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao NovelBeam Technology Co  (SHSE:688677) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Qingdao NovelBeam Technology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Qingdao NovelBeam Technology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao NovelBeam Technology Co (SHSE:688677) Business Description

Traded in Other Exchanges
N/A
Address
No. 100, Weisi Road, Keyuan, Laoshan District, Shandong Province, Qingdao, CHN, 266100
Qingdao NovelBeam Technology Co Ltd is engaged in the research and development, production and sales of medical endoscope equipment and optical products. The product portfolio of the group includes Endoscope, Camera coupler, Camera lens, Medical optics, Biometrics and others.
Executives
Wang Fang Hua senior management
Mao Rong Zhuang Core technical personnel
Zheng Jin Lan Supervisors

Qingdao NovelBeam Technology Co (SHSE:688677) Headlines

No Headlines